Cardiodx
Redwood City, US · Delaware corporation · 2 known investors
Find your way into Cardiodx
Sign up to see every warm intro you have to Cardiodx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cardiodx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Molecular diagnostics company commercializing tools for diagnosing cardiovascular disease.
Founders & leadership
MM

Mark MonaneExecutive
GR

Gwen R. CarscaddenExecutive
DL
David L. LevisonExecutive
DL

Deborah L. KilpatrickVP Market Development, SVP Commercial2006–2012Deborah L. Kilpatrick is an executive at Cardiodx with experience in research, development, and commercialization of healthcare technologies, medical devices, and diagnostics across Fortune 500 companies and startup environments. She has held operational leadership roles in R&D, technology incubation, and commercialization, and co-founded an annual conference for women in medtech business, investment, and clinical roles.
RF
Robert F. WernerExecutive
DT
Douglas T. RossExecutive
MG
Melinda GriffithExecutive
Board
PG
Patrick G. EnrightBoard director
LL
Louis LangeBoard director
AS
Ajit SinghBoard director
HH
Hongjie HuBoard director
BH
Brook H. ByersBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$51.5M disclosed across 3 rounds · 2014–2017
▶$18.1MraisedJan 2017 · 7 investors · BiotechnologyRule 506(b)
▶$18.1MraisedJan 2017 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hongjie HuDirector
- Mark MonaneExecutive Officer
- Patrick G. EnrightDirector
- Ajit SinghDirector
- David L. LevisonDirector
- Tim HennExecutive Officer
- Khushro F. MehtaExecutive Officer, Director
- Susan DanielsExecutive Officer
- Jim WingroveExecutive Officer
- Duane WilliamsExecutive Officer
- Offering amount
- $41.8M
- Amount sold
- $18.1M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.4MraisedFeb 2016 · 15 investors · BiotechnologyRule 506(b)
▶$12.4MraisedFeb 2016 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark MonaneExecutive Officer
- Patrick G. EnrightDirector
- Gwen R. CarscaddenExecutive Officer
- Louis LangeDirector
- Andrew L. GuggenhimeDirector
- James R. TobinDirector
- David L. LevisonExecutive Officer, Director
- Ajit SinghDirector
- Hongjie HuDirector
- Offering amount
- $25.5M
- Amount sold
- $12.4M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21MraisedJul 2014 · 14 investors · BiotechnologyRule 506(c)
▶$21MraisedJul 2014 · 14 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Patrick G. EnrightDirector
- David L. LevisonExecutive Officer, Director
- Mark MonaneExecutive Officer
- Brook H. ByersDirector
- Deborah L. KilpatrickExecutive Officer
- Robert F. WernerExecutive Officer
- Andrew L. GuggenhimeDirector
- Douglas T. RossExecutive Officer
- Melinda GriffithExecutive Officer
- Ajit SinghDirector
- Gwen R. CarscaddenExecutive Officer
- Louis LangeDirector
- James R. TobinDirector
- Offering amount
- $25M
- Amount sold
- $21M
- First sale
- Jul 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Cardiodx do?
- Molecular diagnostics company commercializing tools for diagnosing cardiovascular disease.
- Who are Cardiodx's investors?
- Cardiodx's investors include Longitude Capital, Pappas Capital.
- How much funding has Cardiodx raised?
- Cardiodx has disclosed $51.5M raised across 3 rounds.
- Where is Cardiodx headquartered?
- Cardiodx is headquartered in Redwood City, US.
